Protagonist Therapeutics Inc (PTGX)
40.39
-0.72
(-1.75%)
USD |
NASDAQ |
Nov 18, 16:00
39.00
-1.39
(-3.44%)
Pre-Market: 08:15
Protagonist Therapeutics Debt to Equity Ratio: 0.00 for Sept. 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2024 | 0.00 |
| June 30, 2024 | 0.00 |
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| Date | Value |
|---|---|
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.1569 |
| December 31, 2019 | 0.1225 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Jun 2020
0.1569
Maximum
Mar 2020
0.014
Average
--
Median
Jun 2020
Debt to Equity Ratio Benchmarks
| Johnson & Johnson | 0.5096 |
| Assembly Biosciences Inc | 0.00 |
| Precision BioSciences Inc | 0.3434 |
| Entrada Therapeutics Inc | 0.00 |
| NovaBay Pharmaceuticals Inc | 0.0476 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 603.86M |
| Total Liabilities (Quarterly) | 71.94M |
| Shareholders Equity (Quarterly) | 531.92M |
| Current Ratio | 10.70 |